Table 1

Patient characteristics

Patient number Diagnosis Clinical activity Leucocyte scan Disease extent E-selectin scan Disease extent WBC count ESR/CRP Treatment
1UCSevere + Pancolitis + Pancolitis18.2126/1105-ASA, prednisolone  (local + systemic)
2UCSevere + Pancolitis + Pancolitis17112/905-ASA, prednisolone  (local + systemic)
3UCSevere + Transverse + descending colon + Transverse + descending colon16.498/102Sulphasalazine,  prednisolone, azathioprine
4UCModerate + Descending + sigmoid colon + Descending + sigmoid colon13.487/835ASA + prednisolone  enema
5UCModerate + Sigmoid colon + rectum + Sigmoid colon + rectum11.957/425ASA + prednisolone  enema + oral prednisolone
6UCModerate + Sigmoid colon + Sigmoid colon11.649/365ASA + prednisolone
7UCMild + Sigmoid (a small segment) 11.632/215ASA + prednisolone  enema
8UCMild + Rectum11.227/185ASA
9UCInactive 8.911/45ASA
10UCInactive 8.49/5Sulphasalazine
1CD3501-150 + Ileum (4 lesions) + Ileum (4 lesions)17.2114/1105-ASA, prednisolone,  azathioprine
2CD3851-150 + Ileum (3 lesions) + caecum + Ileum (3 lesions) + caecum15.194/845-ASA, prednisolone
3CD4101-150 + Ileum (5 lesions) + caecum + Ileum (5 lesions) + caecum14.6132/90Prednisolone
4CD2651-150 + Terminal ileum + caecum + Terminal ileum + caecum12.276/525-ASA, prednisolone
5CD1901-150 + Ileum (1 lesion) 11.127/32Prednisolone
6CD801-150 8.114/8No medication
7CD701-150 7.68/6No medication
  • 1-150 Disease activity measured by Crohn’s Disease Activity Index.

  • UC, ulcerative colitis; CD, Crohn’s disease; WBC, white blood cell; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; 5-ASA, 5-acetylsalicylic acid.